Automate Your Wheel Strategy on IVF
With Tiblio's Option Bot, you can configure your own wheel strategy including IVF - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol IVF
- Rev/Share 4.746
- Book/Share 2.401
- PB 0.7538
- Debt/Equity 2.6496
- CurrentRatio 0.0838
- ROIC -1.3008
- MktCap 1680172.0
- FreeCF/Share -4.6129
- PFCF -0.2622
- PE -0.101
- Debt/Assets 0.2784
- DivYield 0
- ROE -5.7172
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025
Published: July 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
SARASOTA, Fla., July 17, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (“INVO”) (NASDAQ: IVF), a healthcare company focused on the fertility market, announced today that it will effect a 1-for-3 reverse split of its issued and outstanding and authorized common stock effective as of 12:01 a.m. Eastern Time on July 21, 2025. Commencing with the opening of trading on The Nasdaq Capital Market on July 21, 2025, the Company's common stock will trade on a post-split basis under the same trading symbol, “IVF”.
Read More
INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
Published: July 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
SARASOTA, Fla., July 09, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare company focused on the fertility market, today announced further efforts to drive its comprehensive strategy to enhance fertility services through expanded clinical and embryology training support and improved pricing for its innovative INVOcell® technology. This underscores the Company's dual mission as an innovator of cutting-edge fertility solutions and a provider of compassionate, patient-centered clinical care through its established fertility clinics and is complementary to the Company's focus on expanding its fertility clinic operations.
Read More
INVO Fertility's Wisconsin Clinic Recognized on Newsweek's List of America's Best Fertility Clinics for 2025
Published: June 16, 2025 by: GlobeNewsWire
Sentiment: Neutral
MIDDLETON, Wis. and SARASOTA, Fla., June 16, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced that its Wisconsin Fertility Institute clinic has been included on Newsweek's list of America's Best Fertility Clinics for 2025.
Read More
About NAYA Biosciences, Inc. Common Stock (IVF)
- IPO Date 2025-01-14
- Website https://www.invobio.com
- Industry Medical - Healthcare Plans
- CEO Steven M. Shum
- Employees 33